Lithium Toxicity & Hemodialysis Indications
Evidence-based emergency management of acute, acute-on-chronic, and chronic lithium poisonings: proximal tubular sodium reabsorption kinetics, nephrogenic diabetes insipidus, neurological coarse tremors and choreoathetosis, irreversible neurotoxicity (SILENT syndrome), aggressive sodium chloride hydration, and protocolized indications for emergent hemodialysis.
Resuscitation Quick Actions • First 2 Minutes
Therapeutic Range
0.6 to 1.2 mEq/L; toxicity develops above 1.5–2.0 mEq/L (chronic patients toxic at lower levels than acute)
First-Line Hydration
0.9% Normal Saline at 200–250 mL/hr to restore intravascular volume, enhance GFR, and competitively inhibit proximal tubular lithium reabsorption
Avoid Diuretics
Thiazides, ACE inhibitors, and NSAIDs dramatically increase lithium levels by promoting proximal tubular sodium and lithium reabsorption
Dialysis: Acute Ingestion
Hemodialysis indicated if serum lithium > 4.0 mEq/L (or > 2.5 mEq/L with severe neurologic symptoms, renal failure, or dysrhythmias)
Dialysis: Chronic Toxicity
Hemodialysis indicated if serum lithium > 2.5 mEq/L with ANY neurologic signs (tremor, ataxia, confusion) or > 3.0–3.5 mEq/L regardless of symptoms
Post-Dialysis Rebound
Check lithium levels 6–8 hours post-dialysis; rebound occurs as intracellular and tissue lithium redistributes into the vascular compartment
Bottom-Line Clinical Pearl
Lithium is an univalent cation excreted entirely by the kidneys that mimics sodium throughout biological systems. Chronic toxicity in long-term users with dehydration or acute kidney injury carries far higher neurotoxicity and mortality than acute single ingestions because brain tissue levels have fully equilibrated. Look for coarse tremor, hyperreflexia, clonus, ataxia, and delirium. The therapeutic window is narrow (0.6–1.2 mEq/L). Volume resuscitation with 0.9% Normal Saline is the initial medical mainstay to restore GFR and promote renal clearance. Hemodialysis is the definitive treatment for severe poisoning (levels > 4.0 mEq/L acute, or > 2.5 mEq/L chronic with neurotoxicity).
Lithium is a monovalent cation with no plasma protein binding, a volume of distribution of 0.7–0.9 L/kg, and complete elimination via the kidneys. Because the kidney handles lithium identically to sodium, 80% of filtered lithium is reabsorbed in the proximal convoluted tubule. Any state of sodium depletion, hypovolemia, or reduced renal perfusion triggers aldosterone and angiotensin II release, driving massive proximal tubular sodium and lithium reabsorption, precipitating toxicity.
| Toxicity Pattern | Precipitating Etiology | Brain vs. Blood Ratio | Severity of Neurotoxicity |
|---|---|---|---|
| Acute Ingestion | Large single ingestion in lithium-naive patient | Low brain:blood ratio (slow CNS transit across blood-brain barrier) | Primarily GI symptoms (vomiting, diarrhea); neurologic symptoms mild or delayed unless massive. |
| Acute-on-Chronic | Patient on maintenance lithium ingests an intentional overdose | Intermediate brain:blood ratio | Severe GI and emerging neurologic signs; high risk of cardiac conduction delays. |
| Chronic Toxicity | Maintenance patient experiences volume depletion, AKI, or drug interaction (NSAIDs, ACEi, thiazides) | High brain:blood ratio (tissues fully saturated) | Profound neurotoxicity (ataxia, coarse tremors, clonus, encephalopathy, choreoathetosis) with relatively lower serum levels. |
Because lithium is a small, water-soluble ion with zero protein binding, it is exceptionally dialyzable via intermittent hemodialysis. Follow the EXTRIP (Extracorporeal Treatments in Poisoning) consensus guidelines:
| Clinical Scenario | Serum Lithium Threshold | Dialysis Recommendation |
|---|---|---|
| Severe Neurologic Manifestations | Any level > 2.0 mEq/L with seizures, coma, or life-threatening dysrhythmias | Dialysis Mandatory regardless of serum concentration. |
| Chronic Poisoning with Symptoms | Serum Lithium > 2.5 mEq/L with moderate neurotoxicity (confusion, ataxia, clonus) | Dialysis Recommended. |
| Acute Ingestion (Asymptomatic or Mild) | Serum Lithium > 4.0 mEq/L | Dialysis Recommended. |
| Renal Failure (Oliguric/GFR < 30) | Serum Lithium > 2.0 mEq/L in patient unable to excrete lithium renally | Dialysis Recommended. |
Clinical Caution
WATCH FOR SILENT SYNDROME: Syndrome of Irreversible Lithium-Effectuated Neurotoxicity (SILENT) is a permanent neurological sequela characterized by persistent cerebellar ataxia, dysarthria, dementia, and choreoathetosis persisting months after lithium levels normalize. Prolonged hyperpyrexia, delay in hemodialysis, and chronic toxicity are major risk factors.
Test Your Lithium Toxicity & Hemodialysis Indications Clinical Acumen
Directly launch an active-recall practice block from our 8,400+ validated COMLEX Level 1, 2-CE & 3 board question bank with complete explanations.
Related Emergency Protocols & Differentials
Acute Kidney Injury & Emergent Dialysis
Hemodialysis access and clearance criteria.
Open Protocol Related EM ProtocolAltered Mental Status & Coma
Comprehensive metabolic coma algorithms.
Open Protocol Related EM ProtocolFluid & Electrolyte Emergencies
Sodium, potassium, and osmolality disorders.
Open Protocol